BMO cuts Mosaic stock price target on sulphur volatility concerns By Investing.com

BMO Capital cut Mosaic’s price target to $31 from $35 while keeping an Outperform rating, citing near-term headwinds from sulphur and stripping margin volatility. The firm expects Q2 EBITDA in the low $400 million range and Q3 EBITDA in the low $500 million range, both described as highly volatile, while Mosaic’s Q1 2026 EPS came in at $0.05 versus $0.2335 expected on revenue of $3.0 billion versus $2.89 billion consensus. The stock trades at $21.76, near its 52-week low of $20.89, with a 4% dividend yield.

Analysis

MOS looks like a classic post-miss “value trap vs. cyclical inflection” debate, but the market is probably underpricing how much of the next 1-2 quarters is tied to operating leverage in inputs rather than just end-demand. When sulphur and stripping volatility are high, earnings power can swing faster than revenue, so even a stable top line can produce another round of negative estimate revisions. That matters because fertilizer stocks tend to re-rate on visible margin stability, not on cheap absolute multiples.

The key second-order effect is that lower near-term confidence compresses the market’s willingness to pay for long-dated normalization. If consensus starts anchoring on 2026-2027 earnings, MOS can still stay weak for months because the equity is effectively being traded as a “show-me” story until the market sees cleaner realized margins. That creates a window where options implied volatility may be mispriced relative to the likely sequence of earnings downgrades and sentiment washout.

On the other side, this setup is most dangerous for shorts if fertilizer pricing or feedstock costs turn simultaneously favorable, because the operating leverage is large and the stock is already near stress levels. The dividend also provides a floor for patient capital, which can limit outright downside unless the next print confirms another earnings reset. In other words, the bear case is more about dead money and multiple compression over 1-3 quarters than a clean fundamental collapse.

Consensus may be missing that the real catalyst is not the next quarter’s EBITDA, but whether management can narrow the range of outcomes. If they do, even a modest improvement in margin visibility could trigger a sharp rerating from depressed sentiment. If they do not, the stock can continue to drift lower despite being statistically cheap on normalized metrics.

Key Decisions for Investors

• Avoid initiating a fresh outright long in MOS before the next earnings cycle; wait for evidence that stripping/sulphur volatility is stabilizing. Risk/reward is poor over the next 1-2 quarters because estimate revisions can outweigh valuation support.
• Consider a short-dated call spread sale or covered-call overlay on existing MOS longs into the next print. The stock’s low multiple caps upside in the near term, while implied volatility should remain supported by earnings uncertainty.
• For investors seeking fertilizer exposure, pair long CF against short MOS over the next 1-3 months. CF has cleaner earnings visibility and should outperform if the market continues to reward de-risked margin profiles.
• If MOS sells off another 8-12% without a change in fundamentals, start scaling a tactical long for a 6-12 month mean reversion trade. The dividend and low valuation offer a decent medium-term floor, but only after the market has fully priced in another downgrade cycle.
• Keep a tight stop on any tactical MOS long: a break below the prior 52-week low on volume would signal the market is moving from cyclical concern to structural de-rating.